Compare GMED & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMED | OWL |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 9.6B |
| IPO Year | 2012 | N/A |
| Metric | GMED | OWL |
|---|---|---|
| Price | $87.83 | $12.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | ★ $97.15 | $20.57 |
| AVG Volume (30 Days) | 1.2M | ★ 24.2M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 7.14% |
| EPS Growth | ★ 358.86 | N/A |
| EPS | ★ 3.08 | 0.10 |
| Revenue | $2,769,804,000.00 | ★ $2,870,178,000.00 |
| Revenue This Year | $17.97 | $12.01 |
| Revenue Next Year | $8.61 | $15.55 |
| P/E Ratio | ★ $28.66 | $126.10 |
| Revenue Growth | 11.75 | ★ 25.04 |
| 52 Week Low | $51.79 | $10.88 |
| 52 Week High | $101.40 | $24.28 |
| Indicator | GMED | OWL |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 34.01 |
| Support Level | $86.53 | $10.88 |
| Resistance Level | $89.64 | $13.10 |
| Average True Range (ATR) | 2.38 | 0.72 |
| MACD | -0.49 | -0.10 |
| Stochastic Oscillator | 22.11 | 35.04 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Blue Owl Capital is one of the world's largest alternative-asset managers, $295.6 billion in total managed assets, including $183.8 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, (with $68.8 billion in total AUM and $40.2 billion in fee-earning AUM), private credit ($152.1 billion/$97.3 billion), and real estate/real assets ($74.7 billion/$46.3 billion). The firm primarily serves institutional investors (68% of AUM) and high-net-worth individuals (32%). The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.